Brief: KORU Medical Systems Announces Subcutaneous Immunoglobulin Prefilled Syringe Development Agreement
25/01/2023 12:11
Jan 25 (Reuters) - KORU Medical Systems Inc KRMD.O :
* KORU MEDICAL SYSTEMS ANNOUNCES SUBCUTANEOUS IMMUNOGLOBULIN
PREFILLED SYRINGE DEVELOPMENT AGREEMENT
* KORU MEDICAL SYSTEMS INC - TERMS OF AGREEMENT WERE NOT
DISCLOSED
Source text for Eikon: ID:nBwc187J7a
Further company coverage: KRMD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Koru Medical Systems
See all newsKoru Medical Systems Inc Reports Results For The Quarter Ended June 30: Earnings Summary
KORU Medical Q2 returns to profit on lower manufacturing costs and higher average selling prices
Brief: KORU Medical Systems Q2 Operating Expenses USD 7.2 Million
Koru Medical Systems Inc Expected To Post A Loss Of 2 Cents A Share: Earnings Preview
Brief: Koru Medical Systems - Enters Amendment No. 1 To Supply Agreement With Command Medical Products On June 24, 2026 - SEC Filing